World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

THE RELATIONSHIP BETWEEN HLA CLASS II ALLELES AND IMMUNOLOGICAL STATUS OF PATIENTS WITH HIV-ASSOCIATED TUBERCULOSIS IN LATVIA

Inga Azina,* Jelena Eglite, Oksana Kolesova, Aleksandrs Kolesovs, Jelena Storozenko, Gunta Sture, Elvira Hagina, Baiba Rozentale and Aivars Lejnieks

ABSTRACT

Aims: To demonstrate the relationship between HLA Class II alleles related to tuberculosis predisposition and resistance and markers of patients immunological status (CD4+ cells count, IFN-? and IL-10), and the activity of HIV-1 infection (viral load). Study design: Combined cross-sectional comparison and correlative study. Place and Duration of Study: Riga East University Hospital, Latvian Centre of Infectious Disease between January 2012 and January 2016. Methodology: HIV-1/TB group included 158 patients at age from 23 to 59 with HIV-1 infection and with confirmed tuberculosis. HIV-1 group included 100 patients at age from 18 to 48 with HIV-1 infection without tuberculosis. HLA typing of DRB1, DQA1, and DQB1 loci was performed by RT-PCR with sequence-specific primers (DNA-Technology, Russia). Levels of cytokines in plasma were measured using ELISA method by Vector-Best kits (Russia). CD4+ cells count detection was provided using CD4 % easy count kit, (Germany). Viral load (HIV-1 RNA) was performed by COBASĀ® AmpliPrep/COBASĀ® TaqMan HIV-1 Test, version 2.0. Results: Five protective and four risk alleles were associated with genetic predisposition to tuberculosis. In HIV-1/TB group, the risk allele HLA-DQB1*04:01 is associated with lower CD4+ cells count, higher viral load and higher level of IL-10. Protective alleles (HLA-DRB1*01, HLA-DQA1*01:02, HLADQB1* 06:02) are related to higher CD4+ cells count, lower viral load, lower IL-10, and longer interval between HIV-1 beginning and detection of tuberculosis. Conclusion: HLA Class II alleles are responsible for the genetic predisposition to HIV-associated tuberculosis and can impact the course of this disease.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR